Charles Schwab’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,373,301
Closed -$32.5M 3099
2015
Q4
$32.5M Buy
1,373,301
+122,685
+10% +$2.85M 0.04% 404
2015
Q3
$25M Buy
1,250,616
+69,254
+6% +$1.38M 0.04% 469
2015
Q2
$22.8M Buy
1,181,362
+173,547
+17% +$3.59M 0.03% 519
2015
Q1
$22.8M Buy
1,007,815
+91,363
+10% +$2.1M 0.03% 505
2014
Q4
$19.7M Buy
916,452
+82,700
+10% +$1.76M 0.03% 522
2014
Q3
$16.8M Sell
833,752
-189,799
-19% -$4.12M 0.03% 552
2014
Q2
$22.3M Buy
1,023,551
+37,423
+4% +$795K 0.04% 450
2014
Q1
$20.2M Buy
986,128
+142,360
+17% +$2.81M 0.04% 456
2013
Q4
$15.3M Buy
843,768
+45,996
+6% +$872K 0.03% 518
2013
Q3
$15.1M Buy
797,772
+52,826
+7% +$1.04M 0.03% 483
2013
Q2
$15M Buy
+744,946
New +$16.1M 0.03% 455

Other funds holding BMR

Charles Schwab's BMR Position: Q1 2016 in Review

Charles Schwab sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 1,373,301 shares — an estimated $32.5M sold.

Charles Schwab first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $32.5M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Charles Schwab reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Charles Schwab sold 1,373,301 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $32.5M.
  • Charles Schwab first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Charles Schwab's BIOMED REALTY TRUST INC position peaked at $32.5M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Charles Schwab's 13F filing for Q1 2016, filed 5 May 2016.